Delivery of Therapeutic siRNA to the Lung Endothelium via Novel Lipoplex Formulation DACC
Open Access
- 1 April 2014
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 22 (4), 811-820
- https://doi.org/10.1038/mt.2013.291
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Atu027 Prevents Pulmonary Metastasis in Experimental and Spontaneous Mouse Metastasis ModelsClinical Cancer Research, 2010
- Vascular endothelial platelet endothelial cell adhesion molecule 1 (PECAM-1) regulates advanced metastatic progressionProceedings of the National Academy of Sciences of the United States of America, 2010
- Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticlesNature, 2010
- Targeted Delivery of Nucleic Acid-Based Therapeutics to the Pulmonary CirculationThe AAPS Journal, 2009
- Tumor metastasis: mechanistic insights and clinical challengesNature Medicine, 2006
- Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acidsJournal of Controlled Release, 2005
- The Role of Organ Vascularization and Lipoplex-Serum Initial Contact in Intravenous Murine LipofectionJournal of Biological Chemistry, 2003
- An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cellsNature, 2000
- Biodistribution and Gene Expression of Lipid/Plasmid Complexes after Systemic AdministrationHuman Gene Therapy, 1998
- Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegansNature, 1998